O	0	11	Multicentre	Multicentre	JJ	B-NP
O	12	17	study	study	NN	I-NP
O	18	20	on	on	IN	B-PP
O	21	25	peri	peri	AFX	B-NP
O	25	26	-	-	HYPH	I-NP
O	27	30	and	and	CC	I-NP
O	31	44	postoperative	postoperative	JJ	I-NP
B-Multi-tissue_structure	45	52	central	central	JJ	I-NP
I-Multi-tissue_structure	53	59	venous	venous	JJ	I-NP
O	60	66	oxygen	oxygen	NN	I-NP
O	67	77	saturation	saturation	NN	I-NP
O	78	80	in	in	IN	B-PP
O	81	85	high	high	JJ	B-NP
O	85	86	-	-	HYPH	I-NP
O	86	90	risk	risk	NN	I-NP
O	91	99	surgical	surgical	JJ	I-NP
O	100	108	patients	patient	NNS	I-NP
O	108	109	.	.	.	O

O	110	122	INTRODUCTION	INTRODUCTION	NN	B-NP
O	122	123	:	:	:	O

O	124	127	Low	Low	JJ	B-NP
B-Multi-tissue_structure	128	135	central	central	JJ	I-NP
I-Multi-tissue_structure	136	142	venous	venous	JJ	I-NP
O	143	149	oxygen	oxygen	NN	I-NP
O	150	160	saturation	saturation	NN	I-NP
O	161	162	(	(	(	O
O	162	167	ScvO2	ScvO2	NN	B-NP
O	167	168	)	)	)	O
O	169	172	has	have	VBZ	B-VP
O	173	177	been	be	VBN	I-VP
O	178	188	associated	associate	VBN	I-VP
O	189	193	with	with	IN	B-PP
O	194	203	increased	increase	VBN	B-NP
O	204	208	risk	risk	NN	I-NP
O	209	211	of	of	IN	B-PP
O	212	225	postoperative	postoperative	JJ	B-NP
O	226	239	complications	complication	NNS	I-NP
O	240	242	in	in	IN	B-PP
O	243	247	high	high	JJ	B-NP
O	247	248	-	-	HYPH	I-NP
O	248	252	risk	risk	NN	I-NP
O	253	260	surgery	surgery	NN	I-NP
O	260	261	.	.	.	O

O	262	269	Whether	Whether	IN	B-SBAR
O	270	274	this	this	DT	B-NP
O	275	286	association	association	NN	I-NP
O	287	289	is	be	VBZ	B-VP
O	290	296	centre	centre	AFX	B-ADJP
O	296	297	-	-	HYPH	B-NP
O	297	305	specific	specific	JJ	I-NP
O	306	308	or	or	CC	I-NP
O	309	313	more	more	RBR	I-NP
O	314	327	generalisable	generalisable	JJ	I-NP
O	328	330	is	be	VBZ	B-VP
O	331	334	not	not	RB	O
O	335	340	known	know	VBN	B-ADJP
O	340	341	.	.	.	O

O	342	345	The	The	DT	B-NP
O	346	349	aim	aim	NN	I-NP
O	350	352	of	of	IN	B-PP
O	353	357	this	this	DT	B-NP
O	358	363	study	study	NN	I-NP
O	364	367	was	be	VBD	B-VP
O	368	370	to	to	TO	B-VP
O	371	377	assess	assess	VB	I-VP
O	378	381	the	the	DT	B-NP
O	382	393	association	association	NN	I-NP
O	394	401	between	between	IN	B-PP
O	402	406	peri	peri	AFX	B-NP
O	406	407	-	-	HYPH	I-NP
O	408	411	and	and	CC	I-NP
O	412	425	postoperative	postoperative	JJ	I-NP
O	426	431	ScvO2	ScvO2	NN	I-NP
O	432	435	and	and	CC	I-NP
O	436	443	outcome	outcome	NN	I-NP
O	444	446	in	in	IN	B-PP
O	447	451	high	high	JJ	B-NP
O	451	452	-	-	HYPH	I-NP
O	452	456	risk	risk	NN	I-NP
O	457	465	surgical	surgical	JJ	I-NP
O	466	474	patients	patient	NNS	I-NP
O	475	477	in	in	IN	B-PP
O	478	479	a	a	DT	B-NP
O	480	491	multicentre	multicentre	JJ	I-NP
O	492	499	setting	setting	NN	I-NP
O	499	500	.	.	.	O

O	501	508	METHODS	METHODS	NNS	B-NP
O	508	509	:	:	:	O

O	510	515	Three	Three	CD	B-NP
O	516	521	large	large	JJ	I-NP
O	522	530	European	European	JJ	I-NP
O	531	541	university	university	NN	I-NP
O	542	551	hospitals	hospital	NNS	I-NP
O	552	553	(	(	(	O
O	553	556	two	two	CD	B-NP
O	557	559	in	in	IN	B-PP
O	560	567	Finland	Finland	NNP	B-NP
O	567	568	,	,	,	O
O	569	572	one	one	CD	B-NP
O	573	575	in	in	IN	B-PP
O	576	587	Switzerland	Switzerland	NNP	B-NP
O	587	588	)	)	)	O
O	589	601	participated	participate	VBD	B-VP
O	601	602	.	.	.	O

O	603	605	In	In	IN	B-PP
O	606	608	60	60	CD	B-NP
O	609	617	patients	patient	NNS	I-NP
O	618	622	with	with	IN	B-PP
O	623	628	intra	intra	AFX	B-NP
O	628	629	-	-	HYPH	I-NP
B-Organism_subdivision	629	638	abdominal	abdominal	JJ	I-NP
O	639	646	surgery	surgery	NN	I-NP
O	647	654	lasting	last	VBG	B-VP
O	655	659	more	more	JJR	B-NP
O	660	664	than	than	IN	I-NP
O	665	667	90	90	CD	I-NP
O	668	675	minutes	minute	NNS	I-NP
O	675	676	,	,	,	O
O	677	680	the	the	DT	B-NP
O	681	689	presence	presence	NN	I-NP
O	690	692	of	of	IN	B-PP
O	693	695	at	at	IN	B-NP
O	696	701	least	least	JJS	I-NP
O	702	705	two	two	CD	I-NP
O	706	708	of	of	IN	B-PP
O	709	718	Shoemaker	Shoemaker	NNP	B-NP
O	718	719	'	'	POS	B-NP
O	719	720	s	s	JJ	I-NP
O	721	729	criteria	criterion	NNS	I-NP
O	729	730	,	,	,	O
O	731	734	and	and	CC	O
O	735	738	ASA	ASA	NN	B-NP
O	739	740	(	(	(	O
O	740	748	American	American	NNP	B-NP
O	749	756	Society	Society	NNP	I-NP
O	757	759	of	of	IN	B-PP
O	760	777	Anesthesiologists	Anesthesiologist	NNPS	B-NP
O	777	778	)	)	)	O
O	779	784	class	class	NN	B-NP
O	785	792	greater	great	JJR	B-ADJP
O	793	797	than	than	IN	B-PP
O	798	799	2	2	CD	B-NP
O	799	800	,	,	,	O
O	801	806	ScvO2	ScvO2	NN	B-NP
O	807	810	was	be	VBD	B-VP
O	811	821	determined	determine	VBN	I-VP
O	822	836	preoperatively	preoperatively	RB	B-ADVP
O	837	840	and	and	CC	O
O	841	843	at	at	IN	B-PP
O	844	847	two	two	CD	B-NP
O	848	852	hour	hour	NN	I-NP
O	853	862	intervals	interval	NNS	I-NP
O	863	869	during	during	IN	B-PP
O	870	873	the	the	DT	B-NP
O	874	883	operation	operation	NN	I-NP
O	884	889	until	until	IN	B-PP
O	890	892	12	12	CD	B-NP
O	893	898	hours	hour	NNS	I-NP
O	899	914	postoperatively	postoperatively	RB	B-ADVP
O	914	915	.	.	.	O

O	916	924	Hospital	Hospital	NN	B-NP
O	925	931	length	length	NN	I-NP
O	932	934	of	of	IN	B-PP
O	935	939	stay	stay	NN	B-NP
O	940	941	(	(	(	O
O	941	944	LOS	LOS	NN	B-NP
O	944	945	)	)	)	O
O	946	955	mortality	mortality	NN	B-NP
O	955	956	,	,	,	O
O	957	960	and	and	CC	O
O	961	971	predefined	predefine	VBD	B-VP
O	972	985	postoperative	postoperative	JJ	B-NP
O	986	999	complications	complication	NNS	I-NP
O	1000	1004	were	be	VBD	B-VP
O	1005	1013	recorded	record	VBN	I-VP
O	1013	1014	.	.	.	O

O	1015	1022	RESULTS	RESULTS	NNS	B-NP
O	1022	1023	:	:	:	O

O	1024	1027	The	The	DT	B-NP
O	1028	1031	age	age	NN	I-NP
O	1032	1034	of	of	IN	B-PP
O	1035	1038	the	the	DT	B-NP
O	1039	1047	patients	patient	NNS	I-NP
O	1048	1051	was	be	VBD	B-VP
O	1052	1054	72	72	CD	B-NP
O	1055	1056	+	+	SYM	O
O	1056	1057	/	/	SYM	O
O	1057	1058	-	-	SYM	B-NP
O	1059	1061	10	10	CD	B-NP
O	1062	1067	years	year	NNS	I-NP
O	1068	1069	(	(	(	O
O	1069	1073	mean	mean	NN	B-NP
O	1074	1075	+	+	SYM	O
O	1075	1076	/	/	SYM	O
O	1076	1077	-	-	HYPH	O
O	1078	1086	standard	standard	JJ	B-NP
O	1087	1096	deviation	deviation	NN	I-NP
O	1096	1097	)	)	)	O
O	1097	1098	,	,	,	O
O	1099	1102	and	and	CC	O
O	1103	1113	simplified	simplify	VBN	B-VP
O	1114	1119	acute	acute	JJ	B-NP
O	1120	1130	physiology	physiology	NN	I-NP
O	1131	1136	score	score	NN	I-NP
O	1137	1138	(	(	(	O
O	1138	1142	SAPS	SAPS	NN	B-NP
O	1143	1145	II	II	CD	I-NP
O	1145	1146	)	)	)	O
O	1147	1150	was	be	VBD	B-VP
O	1151	1153	32	32	CD	B-NP
O	1154	1155	+	+	SYM	O
O	1155	1156	/	/	SYM	O
O	1156	1157	-	-	SYM	B-NP
O	1158	1160	12	12	CD	B-NP
O	1160	1161	.	.	.	O

O	1162	1170	Hospital	Hospital	NN	B-NP
O	1171	1174	LOS	LOS	NN	I-NP
O	1175	1178	was	be	VBD	B-VP
O	1179	1181	10	10	CD	B-NP
O	1181	1182	.	.	.	I-NP
O	1182	1183	5	5	CD	I-NP
O	1184	1185	(	(	(	O
O	1185	1186	8	8	CD	B-NP
O	1187	1189	to	to	TO	O
O	1190	1192	14	14	CD	O
O	1192	1193	)	)	)	O
O	1194	1198	days	day	NNS	B-NP
O	1198	1199	,	,	,	O
O	1200	1203	and	and	CC	O
O	1204	1206	28	28	CD	B-NP
O	1206	1207	-	-	HYPH	I-NP
O	1207	1210	day	day	NN	I-NP
O	1211	1219	hospital	hospital	NN	I-NP
O	1220	1229	mortality	mortality	NN	I-NP
O	1230	1233	was	be	VBD	B-VP
O	1234	1236	10	10	CD	B-NP
O	1236	1237	.	.	.	O
O	1237	1238	0	0	CD	B-NP
O	1238	1239	%	%	NN	I-NP
O	1239	1240	.	.	.	O

O	1241	1253	Preoperative	Preoperative	JJ	B-NP
O	1254	1259	ScvO2	ScvO2	NN	I-NP
O	1260	1269	decreased	decrease	VBD	B-VP
O	1270	1274	from	from	IN	B-PP
O	1275	1277	77	77	CD	B-NP
O	1277	1278	%	%	NN	I-NP
O	1279	1280	+	+	SYM	B-NP
O	1280	1281	/	/	SYM	B-VP
O	1281	1282	-	-	SYM	B-NP
O	1283	1285	10	10	CD	B-NP
O	1285	1286	%	%	NN	I-NP
O	1287	1289	to	to	TO	I-NP
O	1290	1292	70	70	CD	I-NP
O	1292	1293	%	%	NN	I-NP
O	1294	1295	+	+	SYM	B-NP
O	1295	1296	/	/	SYM	B-NP
O	1296	1297	-	-	SYM	O
O	1298	1300	11	11	CD	B-NP
O	1300	1301	%	%	NN	I-NP
O	1302	1303	(	(	(	O
O	1303	1304	p	p	NN	B-NP
O	1305	1306	<	<	SYM	B-ADJP
O	1307	1308	0	0	CD	B-NP
O	1308	1309	.	.	.	I-NP
O	1309	1312	001	001	CD	I-NP
O	1312	1313	)	)	)	O
O	1314	1325	immediately	immediately	RB	B-ADVP
O	1326	1331	after	after	IN	B-PP
O	1332	1339	surgery	surgery	NN	B-NP
O	1340	1343	and	and	CC	O
O	1344	1352	remained	remain	VBD	B-VP
O	1353	1362	unchanged	unchanged	JJ	B-ADJP
O	1363	1365	12	12	CD	B-NP
O	1366	1371	hours	hour	NNS	I-NP
O	1372	1377	later	later	RB	B-ADVP
O	1377	1378	.	.	.	O

O	1379	1380	A	A	DT	B-NP
O	1381	1386	total	total	NN	I-NP
O	1387	1389	of	of	IN	B-PP
O	1390	1392	67	67	CD	B-NP
O	1393	1406	postoperative	postoperative	JJ	I-NP
O	1407	1420	complications	complication	NNS	I-NP
O	1421	1425	were	be	VBD	B-VP
O	1426	1434	recorded	record	VBN	I-VP
O	1435	1437	in	in	IN	B-PP
O	1438	1440	32	32	CD	B-NP
O	1441	1449	patients	patient	NNS	I-NP
O	1449	1450	.	.	.	O

O	1451	1456	After	After	IN	B-PP
O	1457	1469	multivariate	multivariate	JJ	B-NP
O	1470	1478	analysis	analysis	NN	I-NP
O	1478	1479	,	,	,	O
O	1480	1484	mean	mean	JJ	B-NP
O	1485	1490	ScvO2	ScvO2	NN	I-NP
O	1491	1496	value	value	NN	I-NP
O	1497	1498	(	(	(	O
O	1498	1502	odds	odd	NNS	B-NP
O	1503	1508	ratio	ratio	NN	I-NP
O	1509	1510	[	[	(	O
O	1510	1512	OR	OR	NN	B-NP
O	1512	1513	]	]	)	O
O	1514	1515	1	1	CD	B-NP
O	1515	1516	.	.	.	I-NP
O	1516	1518	23	23	CD	I-NP
O	1519	1520	[	[	(	O
O	1520	1522	95	95	CD	B-NP
O	1522	1523	%	%	NN	I-NP
O	1524	1534	confidence	confidence	NN	I-NP
O	1535	1543	interval	interval	NN	I-NP
O	1544	1545	(	(	(	O
O	1545	1547	CI	CI	NN	B-NP
O	1547	1548	)	)	)	O
O	1549	1550	1	1	CD	B-NP
O	1550	1551	.	.	.	O
O	1551	1553	01	01	CD	B-NP
O	1554	1556	to	to	TO	I-NP
O	1557	1558	1	1	CD	I-NP
O	1558	1559	.	.	.	I-NP
O	1559	1561	50	50	CD	I-NP
O	1561	1562	]	]	)	O
O	1562	1563	,	,	,	O
O	1564	1565	p	p	NN	B-NP
O	1566	1567	=	=	SYM	B-VP
O	1568	1569	0	0	CD	B-NP
O	1569	1570	.	.	SYM	I-NP
O	1570	1573	037	037	CD	I-NP
O	1573	1574	)	)	)	O
O	1574	1575	,	,	,	O
O	1576	1584	hospital	hospital	NN	B-NP
O	1585	1588	LOS	LOS	NN	I-NP
O	1589	1590	(	(	(	O
O	1590	1592	OR	OR	NN	B-NP
O	1593	1594	0	0	CD	I-NP
O	1594	1595	.	.	.	O
O	1595	1597	75	75	CD	B-NP
O	1598	1599	[	[	(	O
O	1599	1601	95	95	CD	B-NP
O	1601	1602	%	%	NN	I-NP
O	1603	1605	CI	CI	NN	I-NP
O	1606	1607	0	0	CD	I-NP
O	1607	1608	.	.	.	O
O	1608	1610	59	59	CD	B-NP
O	1611	1613	to	to	TO	I-NP
O	1614	1615	0	0	CD	I-NP
O	1615	1616	.	.	.	I-NP
O	1616	1618	94	94	CD	I-NP
O	1618	1619	]	]	)	O
O	1619	1620	,	,	,	O
O	1621	1622	p	p	NN	B-NP
O	1623	1624	=	=	SYM	B-VP
O	1625	1626	0	0	CD	B-NP
O	1626	1627	.	.	SYM	I-NP
O	1627	1630	012	012	CD	I-NP
O	1630	1631	)	)	)	O
O	1631	1632	,	,	,	O
O	1633	1636	and	and	CC	O
O	1637	1641	SAPS	SAPS	NN	B-NP
O	1642	1644	II	II	CD	I-NP
O	1645	1646	(	(	(	O
O	1646	1648	OR	OR	NN	B-NP
O	1649	1650	0	0	CD	I-NP
O	1650	1651	.	.	.	I-NP
O	1651	1653	90	90	CD	I-NP
O	1654	1655	[	[	(	O
O	1655	1657	95	95	CD	B-NP
O	1657	1658	%	%	NN	I-NP
O	1659	1661	CI	CI	NN	I-NP
O	1662	1663	0	0	CD	I-NP
O	1663	1664	.	.	.	I-NP
O	1664	1666	82	82	CD	I-NP
O	1667	1669	to	to	TO	B-PP
O	1670	1671	0	0	CD	B-NP
O	1671	1672	.	.	.	I-NP
O	1672	1674	99	99	CD	I-NP
O	1674	1675	]	]	)	O
O	1675	1676	,	,	,	O
O	1677	1678	p	p	NN	B-NP
O	1679	1680	=	=	SYM	B-VP
O	1681	1682	0	0	CD	B-NP
O	1682	1683	.	.	.	O
O	1683	1686	029	029	CD	B-NP
O	1686	1687	)	)	)	O
O	1688	1692	were	be	VBD	B-VP
O	1693	1706	independently	independently	RB	I-VP
O	1707	1717	associated	associate	VBN	I-VP
O	1718	1722	with	with	IN	B-PP
O	1723	1736	postoperative	postoperative	JJ	B-NP
O	1737	1750	complications	complication	NNS	I-NP
O	1750	1751	.	.	.	O

O	1752	1755	The	The	DT	B-NP
O	1756	1763	optimal	optimal	JJ	I-NP
O	1764	1769	value	value	NN	I-NP
O	1770	1772	of	of	IN	B-PP
O	1773	1777	mean	mean	JJ	B-NP
O	1778	1783	ScvO2	ScvO2	NN	I-NP
O	1784	1786	to	to	TO	B-VP
O	1787	1799	discriminate	discriminate	VB	I-VP
O	1800	1807	between	between	IN	B-PP
O	1808	1816	patients	patient	NNS	B-NP
O	1817	1820	who	who	WP	B-NP
O	1821	1824	did	do	VBD	B-VP
O	1825	1827	or	or	CC	O
O	1828	1831	did	do	VBD	B-VP
O	1832	1835	not	not	RB	I-VP
O	1836	1843	develop	develop	VB	I-VP
O	1844	1857	complications	complication	NNS	B-NP
O	1858	1861	was	be	VBD	B-VP
O	1862	1864	73	73	CD	B-NP
O	1864	1865	%	%	NN	I-NP
O	1866	1867	(	(	(	O
O	1867	1878	sensitivity	sensitivity	NN	B-NP
O	1879	1881	72	72	CD	B-NP
O	1881	1882	%	%	NN	I-NP
O	1882	1883	,	,	,	O
O	1884	1895	specificity	specificity	NN	B-NP
O	1896	1898	61	61	CD	B-NP
O	1898	1899	%	%	NN	I-NP
O	1899	1900	)	)	)	O
O	1900	1901	.	.	.	O

O	1902	1912	CONCLUSION	CONCLUSION	NN	B-NP
O	1912	1913	:	:	:	O

O	1914	1917	Low	Low	JJ	B-NP
O	1918	1923	ScvO2	ScvO2	NN	I-NP
O	1924	1939	perioperatively	perioperatively	RB	B-ADVP
O	1940	1942	is	be	VBZ	B-VP
O	1943	1950	related	relate	VBN	I-VP
O	1951	1953	to	to	TO	B-PP
O	1954	1963	increased	increase	VBN	B-NP
O	1964	1968	risk	risk	NN	I-NP
O	1969	1971	of	of	IN	B-PP
O	1972	1985	postoperative	postoperative	JJ	B-NP
O	1986	1999	complications	complication	NNS	I-NP
O	2000	2002	in	in	IN	B-PP
O	2003	2007	high	high	JJ	B-NP
O	2007	2008	-	-	HYPH	I-NP
O	2008	2012	risk	risk	NN	I-NP
O	2013	2020	surgery	surgery	NN	I-NP
O	2020	2021	.	.	.	O

O	2022	2026	This	This	DT	B-NP
O	2027	2035	warrants	warrant	VBZ	B-VP
O	2036	2042	trials	trial	NNS	B-NP
O	2043	2047	with	with	IN	B-PP
O	2048	2052	goal	goal	NN	B-NP
O	2052	2053	-	-	HYPH	B-NP
O	2053	2061	directed	direct	VBN	I-NP
O	2062	2069	therapy	therapy	NN	I-NP
O	2070	2075	using	use	VBG	B-VP
O	2076	2081	ScvO2	ScvO2	NN	B-NP
O	2082	2084	as	as	IN	B-PP
O	2085	2086	a	a	DT	B-NP
O	2087	2093	target	target	NN	I-NP
O	2094	2096	in	in	IN	B-PP
O	2097	2101	high	high	JJ	B-NP
O	2101	2102	-	-	HYPH	I-NP
O	2102	2106	risk	risk	NN	I-NP
O	2107	2114	surgery	surgery	NN	I-NP
O	2115	2123	patients	patient	NNS	I-NP
O	2123	2124	.	.	.	O

